SRSF1 and small cell lung carcinoma: In small cell lung cancer, SRSF1 silencing suppressed PI3K/AKT and MEK/ERK pathways, activation of the latter was associated with PKB‐mediated phosphorylation of GSK‐3β thereby released and stabilized cytoplasmic β‐catenin 50, 51.